Dr. Luis E. Raez
@LuisRaezMD
Followers
1K
Following
3K
Media
383
Statuses
2K
Chief Sci Off & Med Dir Memorial Can Inst/Memorial Health Syst Past Pres. FLASCO, old account @luiseraez1 was dc, personal site
Miami, FL
Joined April 2023
We are publishing EGFR resistant tumor data here after profiling more than 45,000 tumors, the documentation of the prevalence of resistance mutations (718,721,797 etc.) is very important however we need to increase awareness to repeat molecular profiling after TKI failure to have
6
28
106
Look at the snow bird ❄️ that came to visit us in Florida last night. Great welcoming @JSabari @nyulangone for a night of learning about sequencing of #EGFR #lungcancer therapies with @LuisRaezMD @EddieSantosMD #lcsm
0
1
15
🌍 Mark your calendars - Madrid awaits! ISLB 2026 is returning to Madrid on Nov 7–9, 2026. Join leading scientists and clinicians to explore the latest advances in liquid biopsy and precision medicine! #ISLB2026 #LiquidBiopsy #PrecisionMedicine #CancerDiagnostics
0
9
14
Professor John Heymach giving Keynote lecture on next generation approach for tailoring treatments for EGFR and HER2 mutant NSCLC at the 2025 MaTOS Lung retreat. @LuisRaezMD @christine_lovly @KarenReckampMD @mecmededucation @OncologyInst @FLASCO_ORG @edgardo_ny #MaTOSlung2025
0
5
9
@isliquidbiopsy @UmbertoMalapel1 @ElJanLe @drgandara ISLB is active in 6 of the 7 continents, advancing education, innovation, and the clinical implementation of LB. Grateful to our Turkish colleagues for the invitation @ChristianRolfo @drgandara @ElJanLe @UmbertoMalapel1 @claramayo
0
5
10
📌 SAVE THE DATE – 22–23 May 2026 We are excited to announce the upcoming International Society of Liquid Biopsy (ISLB) Workshop, entitled: “The Path to Leading Innovation in Liquid Biopsy” 📍 HABITA79 MGallery Pompeii – Pompei (NA), Italy 🗓 22–23 May 2026 👥 Chairs:
0
15
20
The #MaTOS conference remains one of the most practical and meaningful forums we have, grounded in real cases and shared learning. Grateful to the Chairs for the invite & for the opportunity to learn together @EddieSantosMD @LuisRaezMD @ReckampK @christine_lovly @DanaFarber
1
4
19
Our #lungcancer #MATOS25 retreat starting tomorrow at Marana AZ with 65 key opinion leaders @delvysra @lungoncdoc @EddieSantosMD @mecmededucation #lcsm
1
7
28
Another fantastic #MaTOS meeting - full of exciting discussions, making new collaborations, and creating special memories with friends in #thoracic #oncology at @RitzCarlton @DoveMountain in beautiful #MaranaAZ #MaTOSLung25 Thank you to the organizers, chairs @LuisRaezMD
1
4
25
Thank you, @LuisRaezMD @KarenReckampMD @christine_lovly @EddieSantosMD for an amazing meeting- fantastic location and just as terrific faculty/organization! #MaTOSLung25
Our Faculty #MaTOSLung2025 #OncologyEducation #LungCancerCare
@EddieSantosMD @LuisRaezMD @KarenReckampMD @NaglaAKarimMD @LauraAlderMD
@LudaBazhenovaMD
@JeffBradleyMD
@DCarboneMD
@yyelamin
@maryjofidlermd
@drgandara
@BalazsHalmosMD
@WadeIams
@iyengarpuneeth
@karenkellymd
0
1
8
Thank you again for the invitation to #MaTOS25! Loved learning, connecting, and sharing meaningful moments with my lung cancer community. Grateful for the opportunity. 🤍🌵 @LuisRaezMD @EddieSantosMD @christine_lovly @mecmededucation
1
2
14
The 2025 MaTOS Lung faculty. On behalf of all my co-chairs (Drs. Reckamp, Lovly and Raez) and the Medical Educator Consoritum thank you for making this edition a successful meeting. God bless you all. @LuisRaezMD @delvysra @StephenVLiu #MaTOSlung2025 @mecmededucation
0
2
14
#MaTOSLung @BiagioRicciutMD @DanaFarber presents one of the most challenging #lungcancer cases Stage IV KRASG12D STK11 PDL1 high w rapid progression 👉🏽highlighting the big area of need to find treatments for patients who have poor IO prognostic indicators
2
4
15
#MaTOS25 @HosseinBorghaei discusses novel approaches to STK11, KEAP1 and TP53 Co-Mutations.
0
2
17
All-star ⭐️ panel for the ‘Other Genomic Alterations’ session. We often discuss genomic alterations as single entities, but co-mutations and other factors can meaningfully influence the effectiveness of targeted therapy and immunotherapy. #MaTOS25 @HosseinBorghaei
1
5
22
How do continue to improve upon our targeted therapy strategies for patients with NSCLC? Dr. John Heymach delivers a masterclass here at #MaTOS25
0
3
25
All star session on targeted therapy and biomarkers in NSCLC at #MaTOS25 with Drs. @delvysra @HosseinBorghaei @ZPiotrowskaMD @drgandara sharing a glimpse of the future of the field.
0
3
26
Honored to have been invited as a faculty member of #MaTOSLung25 alongside so many incredible thoracic leaders in the field! 🙌 @sylvestercancer @mecmededucation
2
6
27
#MaTOSLung25 @JuliaRotow @DanaFarber discusses the emerging role of ctDNA to escalate and de-escalate therapy in #lungcancer 🚫ctDNA not yet ready to guide de-escalation 👍 can be used as prognostic but not predictive tool yet. #liquidbiopsy #lcsm
0
2
13